BVF Partners L P/il, 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 601,482 shares at $3.74 ($2.3M) on 2019-10-04, disclosed to the SEC on 2019-10-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.74 | 7,314 | $27K | 1.2% |
| 2 | $3.74 | 991 | $4K | 0.2% |
| 3 | $3.74 | 7,695 | $29K | 1.3% |
| 4 | $3.75 | 98,333 | $369K | 16.4% |
| 5 | $3.75 | 14,242 | $53K | 2.4% |
| 6 | $3.75 | 80,821 |
| $303K |
| 13.5% |
| 7 | $3.75 | 24,425 | $92K | 4.1% |
| 8 | $3.75 | 138,609 | $520K | 23.1% |
| 9 | $3.75 | 168,640 | $632K | 28.1% |
| 10 | $3.68 | 4,689 | $17K | 0.8% |
| 11 | $3.68 | 24,716 | $91K | 4.0% |
| 12 | $3.68 | 31,007 | $114K | 5.1% |
| Total | $3.74 avg | 601,482 | $2.3M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |